CCK-8 and cell suspension assays demonstrated that ME2-WT promoted the activity and stemness of HCC cells, whereas ME2-R67K lost its ability to promote the activity and stemness of HCC cells (Fig. 2B, C). Here, ME2 is linked to hepatocellular carcinoma.